![Michael Snape](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Snape
Directeur Général chez
AMO Pharma Ltd.
Health Technology
Profil
Michael F.
Snape holds the title of Chief Executive & Scientific Officer at AMO Pharma Ltd. starting in 2015.
Dr. Snape is the founder of AMO Pharma Ltd., founded in 2015, and holds the title of Chief Executive & Scientific Officer.
Dr. Snape is also the founder of Neuropharm Group Plc..
Postes actifs de Michael Snape
| Sociétés | Poste | Début |
|---|---|---|
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology Operates as an biopharmaceutical company that develops new treatments for serious and debilitating diseases | Directeur Général | 01/01/2015 |
Anciens postes connus de Michael Snape
| Sociétés | Poste | Fin |
|---|---|---|
Neuropharm Group Plc
 Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures speciality pharmaceuticals | Fondateur | 12/07/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Neuropharm Group Plc
Neuropharm Group Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures speciality pharmaceuticals | Health Technology |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology Operates as an biopharmaceutical company that develops new treatments for serious and debilitating diseases | Health Technology |
Choisissez Zonebourse 
